Zeta is in a powerful, sustained uptrend, with the stock up 74.49% over the past year and 59.77% year-to-date, dramatically outperforming the S&P 500's 15.53% and 11.93% respective gains. At $31.81, the stock sits at roughly 81% of its 52-week range (low of $14.365, high of $35.75), positioning it in the upper quartile of its annual band — a zone that signals strong momentum but also raises the risk of overextension and profit-taking. The 58.96 percentage-point relative strength advantage over SPY over one year confirms this is a genuine market leader rather than a beta-driven rally. Recent momentum remains positive but is decelerating at the margin: the stock is up 3.11% over the past month and 46.73% over three months, meaning the bulk of gains were front-loaded earlier in the quarter. The 1-month relative strength of 1.89 versus SPY's 1.22% shows Zeta still outperforming, but the modest one-month gain against a 46.73% three-month surge suggests consolidation after a parabolic move rather than fresh acceleration. The most recent session saw a sharp 5.19% single-day drop from $33.55 to $31.81 on elevated volume of 9.7 million shares, a warning sign of distribution that conflicts with the longer-term uptrend and could signal near-term mean reversion. Key technical levels are clear: resistance sits at the 52-week high of $35.75, roughly 12.4% above the current price, and a breakout above that level would confirm a fresh leg higher and likely trigger momentum-chasing inflows. Support rests at the 52-week low of $14.365, though more relevant near-term support likely lies in the high-$20s where the stock consolidated in September; a breakdown below that zone would signal the uptrend is broken. With a beta of 1.392, Zeta is roughly 39% more volatile than the market, and a maximum drawdown of -40.37% over the period underscores that position sizing must account for sharp, sentiment-driven swings.

Zeta's revenue trajectory is one of accelerating, high-velocity growth: Q2 2026 revenue reached $442.77 million, up 43.55% year-over-year from $308.44 million in Q2 2025, and up sequentially from $396.30 million in Q1 2026 and $394.64 million in Q4 2025. The multi-quarter trend shows clear acceleration — year-over-year growth stepped up from the roughly 14% implied by Q1 2025's $264.42 million to Q1 2026's $396.30 million, and the 43.55% Q2 print is the strongest in the dataset. This growth appears partly inorganic, with $47.0 million of acquisitions in Q1 2026 and $89.1 million in Q4 2025, which investors must weigh against organic momentum; nonetheless, the scale of the top-line expansion supports the bull case for Zeta as a share gainer in marketing technology. Profitability has inflected meaningfully: Q2 2026 net income was $8.17 million (EPS $0.0367) versus a net loss of $12.81 million in Q2 2025, and gross margin held at 59.12% (versus 62.07% a year earlier), while operating margin turned positive at 3.82% from -1.66%. The trailing twelve-month picture remains thin — net margin of -2.42% and operating margin of just 0.41% — reflecting the drag from Q1 2026's $13.25 million loss, but the directional trend across the last four quarters (from -$21.6 million in Q1 2025 to +$8.17 million in Q2 2026) is decisively toward profitability. Gross margin compression from 72.73% in Q4 2025 to 59.12% in Q2 2026 warrants monitoring, as it suggests a mix shift toward lower-margin revenue or acquisition-related costs. The balance sheet is solid and improving: debt-to-equity is just 0.2449, the current ratio is 1.60, and cash stood at $309.95 million at Q2 2026. Free cash flow is robust at $224.41 million TTM, with Q2 2026 FCF of $64.36 million on operating cash flow of $69.18 million, and the company is actively returning capital via $29.90 million of buybacks in the quarter. ROE remains slightly negative at -3.92% on a trailing basis, but ROA has turned positive at 2.60%, and the low leverage plus strong FCF generation means Zeta can fund growth and acquisitions internally without external financing dependence — a meaningful de-risking factor.